Humira (adalimumab) and Remicade (infliximab) are prescription drugs used to treat certain inflammatory conditions. Find out how these drugs compare.

Background: ICI use is linked to severe gastrointestinal (GI) immune-related adverse events (irAEs), which affect morbidity and mortality and often require treatment pauses. Among these, ...

TORONTO, March 12, 2025--Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new brand name RemdantryTM ...

A 17-year-old white male with a 9-year history of ileocolonic Crohn's disease developed a skin rash while receiving infliximab, a chimeric IgG1κ monoclonal antibody against tumor necrosis factor ...

Heat rashes look like small flesh-colored or red bumps in the skin, which develop when sweat gets trapped. In its mildest form, a heat rash may also look like tiny, clear fluid-filled blisters ...

Side effects often manifest as drug rashes, lymphocytopenia, gastrointestinal symptoms, and fatigue. Depending on severity, dose adjustments or prolonged, lower-dose therapy may be needed.

To compare cyclophosphamide vs. infliximab (Remicade, Janssen) as first-line therapies in severe Behçet’s syndrome, Saadoun and colleagues conducted a phase 2, open-label, randomized controlled ...

Celltrion has announced groundbreaking results from a two-year study on dose escalation of subcutaneous infliximab (CT-P13 SC) therapy. This news was presented at United European Gastroenterology (UEG ...

Ten patients were randomized to the infliximab arm and nine to the vedolizumab arm. At two weeks, clinical remission rates are similarly high across infliximab (90%) and vedolizumab (88.9%) groups, ...

Mononucleosis results from Epstein-Barr virus infection. People with the condition may develop a range of symptoms, including a skin rash. Learn more.